Highlights

  • Peak Processing Limited (ASX: PKP) held its General Meeting on Thursday 25 June 2026, with resolutions decided by poll.
  • Nine of the ten resolutions were carried by the requisite majority, most with around 98%–99% support.
  • Resolution 8 — approval to issue shares for the Establishment Fee — was NOT passed, with roughly 80% of votes cast against it.
  • Shareholders strongly backed the company's placement ratifications (LR 7.1 and 7.1A), director participation, loan note shares and lead manager options.
  • PKP is an FMCG company specialising in THC (cannabis) beverages for regulated markets including the USA and Canada.
  • The failed Resolution 8 may mean an establishment fee must be settled in cash rather than scrip, or be renegotiated.

Annual and general meetings rarely make headlines, but the latest ASX announcement from Peak Processing Limited (ASX: PKP) is a useful exception. On Thursday 25 June 2026, the cannabis beverage company held a General Meeting at which shareholders voted on ten resolutions by poll. The outcome was overwhelmingly supportive — with one notable exception. Resolution 8, seeking approval to issue shares for an Establishment Fee, was decisively rejected, with around 80% of votes cast against it.

For holders of Peak Processing ASX shares, the result is a clear illustration of shareholders backing a company's broad capital-raising strategy while pushing back on one specific element of its financing arrangements. This company update walks through what the ASX announcement says, explains the technical resolutions in plain English, and considers what the result means for PKP ASX stock going forward.

What the ASX Announcement Says

The announcement, titled "Results of Meeting," reports the outcome of Peak Processing's General Meeting held on 25 June 2026. The resolutions came from the Notice of General Meeting released on 22 May 2026, and were decided by a poll rather than a show of hands. The disclosure is made in accordance with section 251AA of the Corporations Act and ASX Listing Rule 3.13.2, which require companies to publish the results of resolutions and the proxy and voting positions.

In short, all resolutions were passed by the requisite majority except for Resolution 8, which was not passed. The announcement was authorised by the board, with investor enquiries directed to Managing Director and CEO Barry Katzman and to investor relations firm Six Degrees Investor Relations (Henry Jordan).

Key Details From the Announcement

The ten resolutions and their outcomes were as follows:

  • Resolution 1 — Ratification of prior issue of Placement Shares under Listing Rule 7.1: CARRIED (~98% in favour).
  • Resolution 2 — Ratification of prior issue of Placement Shares under Listing Rule 7.1A: CARRIED (~98%).
  • Resolution 3 — Grant of Placement Lead Manager Options to Taurus Capital Group Pty Ltd: CARRIED (~99%).
  • Resolution 4 — Participation of Director Mr Manik Pujara in the Placement: CARRIED (~99%).
  • Resolution 5 — Participation of Director Mr Barry Katzman in the Placement: CARRIED (~99%).
  • Resolution 6 — Issue of Shares to Director Mr Manik Pujara in lieu of fees: CARRIED (~99%).
  • Resolution 7 — Issue of Loan Note Shares: CARRIED (~99%).
  • Resolution 8 — Approval for the issue of shares for the Establishment Fee: NOT CARRIED (~80% against, ~20% in favour).
  • Resolution 9 — Grant of Loan Note Lead Manager Options to Powerhouse Advisory Australia Pty Ltd: CARRIED (~99%).
  • Resolution 10 — Issue of Shares to Director Mr Barry Katzman in lieu of cash remuneration: CARRIED (~99%).

The contrast is stark: nine resolutions cleared comfortably with support typically in the 98%–99% range, while Resolution 8 attracted roughly 80% opposition. That divergence tells investors the rejection was specific and deliberate, not a reflection of broad dissatisfaction with the company.

Why This Matters for Investors

To understand the significance of this ASX news, it helps to decode the resolutions in plain English. Under ASX Listing Rule 7.1, a company can issue up to 15% of its capital in any 12-month period without shareholder approval; eligible companies can access an additional 10% under Listing Rule 7.1A. When a company has already used that capacity in a placement, it often asks shareholders to ratify the issue after the fact. Ratification effectively "refreshes" the company's placement capacity, restoring headroom to raise further capital without needing a separate shareholder vote. Resolutions 1 and 2 did exactly that, and their near-unanimous passage signals strong support for PKP's recent capital raising.

Several resolutions involved related parties. Under Listing Rule 10.11, issuing securities to directors generally requires shareholder approval. Resolutions 4, 5, 6 and 10 covered director participation in the placement and the issue of shares to directors Manik Pujara and Barry Katzman in lieu of fees and cash remuneration. Their approval indicates shareholders are comfortable with management taking scrip — an arrangement that conserves cash and aligns directors' interests with other shareholders. Resolution 7 concerned Loan Note Shares, tied to the company's debt or loan-note funding, while Resolutions 3 and 9 granted options to lead managers Taurus Capital Group and Powerhouse Advisory Australia as part of the fundraising arrangements.

Resolution 8 stands apart. It sought approval to issue shares to settle an Establishment Fee — most likely a fee associated with the funding arrangement, payable in scrip. With around 80% of votes cast against, shareholders signalled they were not willing to dilute themselves to pay that particular fee in shares. This is the single dissent in an otherwise supportive vote, and it is the result that most warrants investor attention.

Company Background

Peak Processing Limited (ASX: PKP) is a fast-moving consumer goods (FMCG) company specialising in the manufacturing, sales and distribution of THC (cannabis) beverages. The company develops premium, compliant products aimed at adult consumers across regulated global markets, including the United States and Canada. As a micro-cap operating in an emerging consumer category, PKP relies on capital raisings and structured funding to support product development, manufacturing and market expansion — which is precisely why the suite of placement, loan-note and related-party resolutions at this General Meeting matters so much to its trajectory.

Market Context

The THC beverage category has been one of the faster-growing segments within the broader cannabis industry in North America, as consumers increasingly seek alcohol alternatives and discreet, dose-controlled formats. Canada's federally regulated market and the patchwork of state-level frameworks in the United States create both opportunity and complexity, with compliance, licensing and distribution rules varying significantly by jurisdiction.

For a micro-cap ASX stock like Peak Processing, the funding environment is equally important. Small companies in emerging categories typically depend on equity placements and convertible or loan-note instruments to bridge to revenue and scale. That makes shareholder approvals for placement capacity, director participation and lead-manager incentives a recurring and material part of the company's story — and helps explain why investors scrutinise the terms closely.

Potential Opportunities

The strong passage of nine resolutions points to genuine opportunities. Ratifying the placements under Listing Rules 7.1 and 7.1A refreshes Peak Processing's placement capacity, giving it flexibility to raise additional capital efficiently if needed. The approval of Loan Note Shares and the associated lead-manager options indicates the company has secured loan-note funding, providing a non-equity source of capital to support operations.

There is also an alignment story. By approving directors taking shares in lieu of fees and cash remuneration, shareholders have endorsed an approach that conserves cash and ties management's rewards to the performance of PKP ASX shares. For a growth-stage business in the THC beverage market, that combination of refreshed capacity, secured funding and aligned management can be a meaningful foundation for execution in the US and Canada.

Potential Risks

The risks, however, are real and worth weighing. The reliance on capital raisings and scrip-based settlements points to ongoing dilution for existing shareholders. The rejection of Resolution 8 introduces a specific question: if the Establishment Fee cannot be settled in shares, the company may need to pay it in cash — a potential drain on working capital — or renegotiate the arrangement. Either outcome could have financial or contractual implications that investors will want clarified.

Beyond financing, Peak Processing faces the regulatory complexity inherent to the cannabis sector, where rules differ across jurisdictions and can change. As a micro-cap, the company is also exposed to small-cap liquidity risk, meaning its shares can be volatile and harder to trade in size. These factors underline why disciplined capital management and clear communication will be important from here.

What Investors Should Watch Next

The first item to watch is how Peak Processing addresses the failed Resolution 8 and the Establishment Fee. Investors will want to know whether the fee will be paid in cash, renegotiated, or restructured, and what that means for the company's cash position. Any follow-up ASX announcement on this point will be informative.

Beyond that, the deployment of the placement and loan-note funds will be telling — specifically, how that capital translates into product development and sales traction in the United States and Canada. Investors should also monitor the company's cash position and any signals about further capital raisings, as these will shape the dilution outlook and the runway available to PKP.

Conclusion

The General Meeting result is a largely positive company update for Peak Processing Limited (ASX: PKP). Shareholders gave overwhelming support to the company's placement ratifications, loan-note funding, director participation and lead-manager arrangements, endorsing the broad capital strategy that underpins its push into the THC beverage market across the United States and Canada. The near-unanimous approvals reflect confidence in the direction management is taking.

Yet the rejection of Resolution 8 is a meaningful detail that investors should not overlook. It shows shareholders are willing to draw a line on specific financing terms, particularly where dilution is involved. As Peak Processing moves to address the Establishment Fee and deploy its newly secured funding, this ASX news will be best read as a vote of confidence with a clear caveat — supportive of the strategy, but watchful on the terms.